Phase
Condition
Hearing Impairment
Deafness
Hearing Loss
Treatment
Cochlear Osia 3 Sound Processor
Cochlear™ Osia® 2 Sound Processor
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Implanted with a Cochlear Osia Implant (OSI100 or OSI200)
Conductive or mixed hearing loss in the implanted ear. Bone conduction threshold 4-frequency pure tone average (PTA4; mean of bone conduction thresholds at 0.5, 1, 2and 4 kHz) ≤ 55 dB HL.
OR Single-Sided Deafness in the implanted ear. Air Conduction threshold 4-frequency pure tone average (PTA4; mean of air conduction thresholds at 0.5, 1, 2 and 3 kHz) ≤ 20 dB HL in the good ear.
Aged 18 years or older, at time of consent.
Minimum experience of 1 month with the Osia 2 Sound Processor.
Fluent speaker in the language used to assess speech perception performance.
Willing and able to provide written informed consent.
Exclusion
Exclusion Criteria:
Sensitivity to loud sounds.
Ongoing infection at or around the sound processor area.
Unable or unwilling to comply with the requirements of the clinical investigation asdetermined by the Investigator.
Use of ototoxic drugs that could be harmful to the hearing, as judged by theinvestigator
Investigator site personnel directly affiliated with this study and/or theirimmediate families; immediate family is defined as a spouse, parent, child, orsibling.
Cochlear employees or employees of Contract Research Organisations or contractorsengaged by Cochlear for the purposes of this investigation.
Current participation, or participation in another interventional clinicalstudy/trial in the past 30 days, involving an investigational drug or device (unlessthe other investigation was/is a Cochlear sponsored investigation and determined bythe investigator or Sponsor to not impact this investigation).
Study Design
Connect with a study center
The HEARing CRC
Melbourne, Victoria 3053
AustraliaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.